SciVision Biotech Inc

SciVision Biotech Inc maintains a strong liquidity position, with a current ratio of 3.16 and cash and equivalents amounting to 554.61 million TWD, which is well above the industry median for liquidity coverage. The company's debt-to-equity ratio of 0.21 indicates a conservative capital structure, with long-term debt of 323.05 million TWD compared to total equity of 1.54 billion TWD. This low leverage supports financial flexibility and reduces exposure to interest rate volatility.

Profitability metrics show a return on equity (ROE) of 3.37% and a return on assets (ROA) of 2.3%, which are below the industry median for ROE and ROA in the medical equipment and supplies sector. The company's net income of 51.70 million TWD on revenue of 195.35 million TWD reflects a net margin of 26.47%, which is strong but not exceptional compared to peers.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of segmental or geographic diversification increases exposure to regional demand fluctuations and regulatory changes in its primary market.

Looking ahead, SciVision Biotech Inc is projected to maintain stable revenue growth, with a year-over-year increase expected in the current fiscal year. However, the outlook for the next fiscal year remains neutral, with no significant acceleration in revenue or earnings anticipated. The company's capital expenditure of -3.84 million TWD suggests a focus on cost optimization rather than expansion.

Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position mitigate credit risk, but its reliance on a single business model and geographic market could pose long-term challenges if demand shifts or regulatory pressures increase.

Recent events include the filing of its latest financial report, which disclosed strong cash generation and stable operating performance. No material changes in business strategy or significant capital commitments were reported in the latest filings or transcripts.

Revenue grew 41% year-over-year to TWD 713 million, demonstrating strong top-line expansion momentum.

Net income surged 74.9% year-over-year, significantly outpacing revenue growth and indicating operating leverage.

Debt-to-equity ratio of 0.21 is below the cohort median, suggesting a conservative capital structure.

Free cash flow turned negative to TWD -93 million in FY2026, reversing previous positive generation trends.

Long-term debt increased to TWD 485 million in FY2026, rising from TWD 224 million in FY2025.

Net income declined to TWD 162 million in FY2026, down from TWD 242 million in FY2025.

Operating income fell to TWD 190 million in FY2026, decreasing from TWD 248 million in FY2025.

Revenue TWD 251.4M, −1,5% YoY; Operating income −17,1% YoY.

• ▍Revenue TWD 251.4M, −1,5% YoY
• ▍Operating income −17,1% YoY
• ▍Net income −3,6% YoY
• ▍Free cash flow −10,6% YoY
• ▍Net margin 25.1%

Revenue TWD 221.4M, −0,4% YoY; Operating income −37,9% YoY.

• ▍Revenue TWD 221.4M, −0,4% YoY
• ▍Operating income −37,9% YoY
• ▍Net income +2,0% YoY
• ▍Free cash flow −20,6% YoY
• ▍Net margin 26.3%

Revenue TWD 209.5M, −0,5% YoY; Operating income −49,5% YoY.

• ▍Revenue TWD 209.5M, −0,5% YoY
• ▍Operating income −49,5% YoY
• ▍Net income −123,6% YoY
• ▍Free cash flow −133,8% YoY
• ▍Net margin -7.7%

Revenue TWD 204.3M, +4,6% YoY; Operating income +26,7% YoY.

• ▍Revenue TWD 204.3M, +4,6% YoY
• ▍Operating income +26,7% YoY
• ▍Net income +10,0% YoY
• ▍Free cash flow −13,1% YoY
• ▍Net margin 27.8%

Revenue TWD 255.2M; Operating income TWD 60.2M.

• ▍Revenue TWD 255.2M
• ▍Operating income TWD 60.2M
• ▍Net margin 25.7%

Revenue TWD 222.2M; Operating income TWD 74.7M.

• ▍Revenue TWD 222.2M
• ▍Operating income TWD 74.7M
• ▍Net margin 25.7%

Revenue TWD 210.6M; Operating income TWD 65.3M.

• ▍Revenue TWD 210.6M
• ▍Operating income TWD 65.3M
• ▍Net margin 32.2%

Revenue TWD 195.4M; Operating income TWD 47.8M.

• ▍Revenue TWD 195.4M
• ▍Operating income TWD 47.8M
• ▍Net margin 26.5%

Revenue TWD 886.6M, +0,4% YoY; Operating income −23,4% YoY.

• ▍Revenue TWD 886.6M, +0,4% YoY
• ▍Operating income −23,4% YoY
• ▍Net income −33,0% YoY
• ▍Free cash flow −189,6% YoY
• ▍Net margin 18.3%

Revenue TWD 883.3M, +23,9% YoY; Operating income +24,3% YoY.

• ▍Revenue TWD 883.3M, +23,9% YoY
• ▍Operating income +24,3% YoY
• ▍Net income +36,2% YoY
• ▍Free cash flow +11,2% YoY
• ▍Net margin 27.4%

Revenue TWD 557.3M, +10,2% YoY; Operating income +10,4% YoY.

• ▍Revenue TWD 557.3M, +10,2% YoY
• ▍Operating income +10,4% YoY
• ▍Net income +39,3% YoY
• ▍Free cash flow +34,9% YoY
• ▍Net margin 25.4%